Eupraxia Pharmaceuticals Inc. (EPRX) KPIs and segments

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30

$8.15+0.34 (+4.35%)

Close on Nov 13, 2026Market cap $491.40MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Eupraxia Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Eupraxia Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?